-
1
-
-
0031841377
-
Cytochrome P450C9: An enzyme of major importance in human drug metabolism
-
Miners JO, Birkett DJ. Cytochrome P450C9: an enzyme of major importance in human drug metabolism. Br J Clin Pharmacol 1998;45;525-38.
-
(1998)
Br J Clin Pharmacol
, vol.45
, pp. 525-538
-
-
Miners, J.O.1
Birkett, D.J.2
-
2
-
-
0141832724
-
Pharmacogenetics of CYP2C9 and interindividual variability in anticoagulant response to warfarin
-
Takahashi H, Echizen H. Pharmacogenetics of CYP2C9 and interindividual variability in anticoagulant response to warfarin. Pharmacogenomics J 2003;3:202-14.
-
(2003)
Pharmacogenomics J
, vol.3
, pp. 202-214
-
-
Takahashi, H.1
Echizen, H.2
-
3
-
-
0034872136
-
Pharmacogenetics of warfarin elimination and its clinical implications
-
Takahashi H, Echizen H. Pharmacogenetics of warfarin elimination and its clinical implications. Clin Pharma-cokinet 2001/40:587-603.
-
(2001)
Clin Pharma-cokinet
, vol.40
, pp. 587-603
-
-
Takahashi, H.1
Echizen, H.2
-
4
-
-
0033608466
-
Association of polymorphisms in the cytochrome P450 CYP2C9 with warfarin dose requirement and risk of bleeding complications
-
Aithal GP, Day CP, Kesteven PJ, Daly AK. Association of polymorphisms in the cytochrome P450 CYP2C9 with warfarin dose requirement and risk of bleeding complications. Lancet 1997;353:717-9.
-
(1997)
Lancet
, vol.353
, pp. 717-719
-
-
Aithal, G.P.1
Day, C.P.2
Kesteven, P.J.3
Daly, A.K.4
-
6
-
-
0037565623
-
Pharmacogenetics of oral anticoagulants
-
Daly AK, King BP. Pharmacogenetics of oral anticoagulants. Pharmacogenetics 2003;13:247-52.
-
(2003)
Pharmacogenetics
, vol.13
, pp. 247-252
-
-
Daly, A.K.1
King, B.P.2
-
7
-
-
0037012465
-
Association between CYP2C9 genetic variants and anticoagutation-related outcomes during warfarin therapy
-
Higahi MK, Veenstra DL, Kondo LM, Wittkowskv AK, Srinouanprachanh SL, Farin FL, et at. Association between CYP2C9 genetic variants and anticoagutation-related outcomes during warfarin therapy. JAMA 2002; 287:1690-8.
-
(2002)
JAMA
, vol.287
, pp. 1690-1698
-
-
Higahi, M.K.1
Veenstra, D.L.2
Kondo, L.M.3
Wittkowskv, A.K.4
Srinouanprachanh, S.L.5
Farin, F.L.6
-
8
-
-
0036194038
-
The frequency and effects of cytochrome P450 (CYP) 2C9 polymorphisms in patients receiving warfarin
-
Tabrizi AR, Zehnbauer BA, Borecki IB, McGrath SD, Buchman TG, Freeman. BD. The frequency and effects of cytochrome P450 (CYP) 2C9 polymorphisms in patients receiving warfarin. J Am Coll Surg 2002;194: 267-73.
-
(2002)
J Am Coll Surg
, vol.194
, pp. 267-273
-
-
Tabrizi, A.R.1
Zehnbauer, B.A.2
Borecki, I.B.3
McGrath, S.D.4
Buchman, T.G.5
Freeman, B.D.6
-
9
-
-
0031807762
-
Metabolism of warfarin enantiomers in Japanese patients with heart disease having different CYP2C9 and CYP2Cl9 genotypes
-
Takahashi H, Kashima T, Nomizo Y, Muramoto N, Shimizu T, Nasu K, et al. Metabolism of warfarin enantiomers in Japanese patients with heart disease having different CYP2C9 and CYP2Cl9 genotypes. Clin Pharmacol Ther 1998;63:519-28.
-
(1998)
Clin Pharmacol Ther
, vol.63
, pp. 519-528
-
-
Takahashi, H.1
Kashima, T.2
Nomizo, Y.3
Muramoto, N.4
Shimizu, T.5
Nasu, K.6
-
10
-
-
0036914221
-
Influence of C-YP2C9 and CYP2C19 genetic polymorphisms on warfarin maintenance dose and metabolic clearance
-
Scordo MG, Pengo V, Spina E, Dahl ML, Gusella M, Padrini R. Influence of C-YP2C9 and CYP2C19 genetic polymorphisms on warfarin maintenance dose and metabolic clearance. Clin Pharmacol Ther 2002;72:702-10.
-
(2002)
Clin Pharmacol Ther
, vol.72
, pp. 702-710
-
-
Scordo, M.G.1
Pengo, V.2
Spina, E.3
Dahl, M.L.4
Gusella, M.5
Padrini, R.6
-
11
-
-
0036263813
-
Cytochrome P450 2C9 polymorphisms: A comprehensive review of the in-vitro and human data
-
Lee CR, Goldstein JA, Pieper JA. Cytochrome P450 2C9 polymorphisms: a comprehensive review of the in-vitro and human data. Pharmacogenetics 2002;12:251-63.
-
(2002)
Pharmacogenetics
, vol.12
, pp. 251-263
-
-
Lee, C.R.1
Goldstein, J.A.2
Pieper, J.A.3
-
12
-
-
0029798351
-
Genetic analysis of the human cytochrome P450 CYP2C9 locus
-
Stubbins MI Harries LW, Smith G, Tarbit MH, Wolf CR. Genetic analysis of the human cytochrome P450 CYP2C9 locus. Pharmacogenetics 1996;6:429-39.
-
(1996)
Pharmacogenetics
, vol.6
, pp. 429-439
-
-
Stubbins, M.I.1
Harries, L.W.2
Smith, G.3
Tarbit, M.H.4
Wolf, C.R.5
-
14
-
-
0003880934
-
Human cytochrome P450 (CYP) genes
-
Available from: URL
-
Ingelman-Sunberg M, Nebert DW, Daly AK. Human cytochrome P450 (CYP) genes. Available from: URL: http://www.imm.ki.se/CYPalleles/cyp2c9.htm
-
-
-
Ingelman-Sunberg, M.1
Nebert, D.W.2
Daly, A.K.3
-
15
-
-
0035040841
-
Frequency of cytochrome P450 2C9 mutant alleles in a Korean population
-
Yoon YR, Shon JH, Kim MK, Lim YC, Lee HR, Park JY, et al. Frequency of cytochrome P450 2C9 mutant alleles in a Korean population. Br J Clin Pharmacol 2001;51:277-80.
-
(2001)
Br J Clin Pharmacol
, vol.51
, pp. 277-280
-
-
Yoon, Y.R.1
Shon, J.H.2
Kim, M.K.3
Lim, Y.C.4
Lee, H.R.5
Park, J.Y.6
-
16
-
-
0348225379
-
Warfarin-associated fetal intracranial hemorrhage: A Case Report
-
Lee HC, Cho SY, Lee HJ, Kim CJ, Park JS, Chi JG. Warfarin - associated fetal intracranial hemorrhage: a Case Report. J Korean Med Sci 2003;18:764-7.
-
(2003)
J Korean Med Sci
, vol.18
, pp. 764-767
-
-
Lee, H.C.1
Cho, S.Y.2
Lee, H.J.3
Kim, C.J.4
Park, J.S.5
Chi, J.G.6
-
17
-
-
0041379113
-
Clinical and functional assessment after anticoagulant therapy of acute deep vein thrombosis involving the lower limb
-
Huh SH, Kim DI, Kim ES, Lee BB, Moon JY, Joh JH. Clinical and functional assessment after anticoagulant therapy of acute deep vein thrombosis involving the lower limb. Yonsei Med J 2003;44:686-93.
-
(2003)
Yonsei Med J
, vol.44
, pp. 686-693
-
-
Huh, S.H.1
Kim, D.I.2
Kim, E.S.3
Lee, B.B.4
Moon, J.Y.5
Joh, J.H.6
-
18
-
-
30644475178
-
Warfarin toxicitv patients in the emergency department
-
Lee JH, Park JS, Chung SW, Sohn DK, Kim SH, Lee HS. Warfarin toxicitv patients in the emergency department. J Korean Soc Emerg Med 2003;14:145-9.
-
(2003)
J Korean Soc Emerg Med
, vol.14
, pp. 145-149
-
-
Lee, J.H.1
Park, J.S.2
Chung, S.W.3
Sohn, D.K.4
Kim, S.H.5
Lee, H.S.6
|